Dr. Vikki Abrahams receives the 2019 American Society for Reproductive Immunology Award
Previously known as the Blackwell Munksgaard Award, the American Journal of Reproductive Immunology Award is presented annually to a senior investigator who has made outstanding contributions to the area of reproductive immunology. Contributions can be in the area of clinical or basic research.
New Stem-cell Cultivation Procedure Boosts Hope for Cures
When the Taylor lab in Yale’s Division of Reproductive Sciences extracted stem cells from human endometrial tissue—more commonly known as the uterine lining—the researchers were proud of their accomplishment. They didn’t think the find was extraordinary, and they certainly didn’t imagine that it might lead to treatments for a neurodegenerative condition. They were wrong—and happily so.
Dr. Sangini S. Sheth selected as one of the ACOG 2018 Immunization Champion Award Winners
New for ACOG in 2018, the Immunization Champion Award recognizes members who have demonstrated exceptional progress in increasing immunization rates among women. The award is intended to recognize ob-gyns who are doing an exemplary job of going above and beyond to educate patients and other providers, as well as increasing access to immunizations in their practice, communities, and the nation. This year ACOG recognizes the hard work and dedication of three selected members who exemplify ACOG’s guidance on immunization for women, one of whom is Dr. Sanguine Sheith, MD from the Yale School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences.
New lead on endometriosis could generate non-hormonal treatments
Researchers in the Yale School of Medicine’s Department of Obstetrics, Gynecology and Reproductive Sciences have made a key finding about endometriosis in humans and mice that could lead to new nonhormonal treatments for the disease.
Women’s Health Research at Yale funds studies on colon cancer, infections in pregnancy, and domestic violence
“Through our competitive peer review process, these three studies stood out as extremely promising opportunities to improve and even save lives,” said Dr. Carolyn M. Mazure, director of WHRY. “With these new grants, we continue to expand a broad scope of existing work to focus on questions vital to the health and well-being of millions of women, men, and children.”
Size matters when it comes to keeping blood sugar levels in check
Keeping blood sugar levels within a safe range is key to managing both type 1 and type 2 diabetes. In a new finding that could lead to fewer complications for diabetes patients, Yale School of Medicine researchers have found that changes in the size of mitochondria in a small subset of brain cells play a crucial role in safely maintaining blood sugar levels.
Connecticut’s premature births increase; state graded a C by March of Dimes
While Connecticut's preterm birth rate increased according to the last March of Dimes prematurity report card, dramatic improvement was seen in New Haven County, decreasing to 8.9% from 9.6%. New Haven County gets a grade of "B".
Researchers find genes behind aggressive ovarian and endometrial cancers
In a major breakthrough for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments. The findings are published in the Oct. 10 online early edition of Proceedings of the National Academy of Sciences.
Fetal BPA exposure in mice linked to estrogen-related diseases after adolescence
Low levels of BPA exposure may be considered safe, but new research published online in The FASEB Journal, suggests otherwise. In the report, researchers from Yale show that the genome is permanently altered in the uterus of mice that had been exposed to BPA during their fetal development. These changes were found to mainly affect genes that are regulated by estrogen and are implicated in the formation of estrogen-related diseases such as infertility, endometriosis, endometrial cancer, osteoporosis, prostate cancer, neurodegenerative disease, obesity and breast cancer.